I-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS 178306-51-9 Ubunyulu ≥99.0% (HPLC) Factory

Inkcazelo emfutshane:

Igama: 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid

CAS: 178306-51-9

Imbonakalo: I-White okanye i-Off-White Powder

Ubunyulu: ≥99.0% (HPLC)

Phakathi (i-CAS: 177036-94-1) kunyango lwe-Pulmonary Arterial Hypertension (PAH)

Inquiry: alvin@ruifuchem.com

Thumela i-imeyile kuthi

Iinkcukacha zeMveliso

Iimveliso ezinxulumeneyo

Iithegi zeMveliso

Inkcazo:

Ubonelelo ngezoRhwebo (CAS: 177036-94-1) abaPhakathi abaNxulumeneyo:
CAS: 177036-94-1
I-Methyl 2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoate CAS: 178306-47-3
I-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid CAS: 178306-51-9
(S)-2-Hydroxy-3-Methoxy-3,3-Diphenylpropionic Acid CAS: 178306-52-0
L-Proline Methyl Ester Hydrochlorid CAS: 2133-40-6
4,6-Dimethyl-2-(Methylsulfonyl)pyrimidine CAS: 35144-22-0

Iipropati zeMichiza:

Igama leMchiza	I-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid
Inombolo yeCAS	178306-51-9
Inombolo yeCAT	RF-PI161
Ubume beStokhwe	Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni
Ifomula yeemolekyuli	C16H16O4
Ubunzima beMolekyuli	272.3
Ukuxinana	1.248
Uphawu	Ruifu Chemical

Iinkcukacha:

Into	Iinkcukacha
Imbonakalo	Umgubo oMhlophe okanye oMhlophe
Ubunyulu	≥99.0% (HPLC)
Ukufuma (KF)	≤1.00%
Ukungacoceki Okukodwa	≤0.50%
Ukungcola ngokupheleleyo	≤1.00%
Umgangatho woVavanyo	Umgangatho woShishino
Ukusetyenziswa	I-Intermediate ye-API (CAS: 177036-94-1)

Ukupakishwa kunye noGcino:

Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Drum, okanye ngokwemfuno yomthengi

Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma

Izinto eziluncedo:

FAQ:

Isicelo:

I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-2-Hydroxy-3-Methoxy-3,3-Diphenylpropanoic Acid (CAS: 178306-51-9) enomgangatho ophezulu, yinto ephambili ephakathi kwe-API (CAS : 177036-94-1).(CAS: 177036-94-1)ngumchasi okhethiweyo we-endothelin-A (ETA) owaziswa kunyango lomlomo lwezigulane ezine-pulmonary arterial hypertension (PAH), ukuphucula umthamo wokuzilolonga kunye nokulibazisa ukonakala kweklinikhi.Ngumchasi wesithathu we-ET-receptor oza kuthengiswa ngolu phawu emva kwe-bosentan kunye ne-sitaxsentan.I-PAH isifo esinqabileyo semibhobho encinci ye-pulmonary ebonakaliswe ngokunyuka kwe-vascular and remodeling, okubangelwa ukunyuka okuqhubekayo kwi-pulmonary vascular resistance and pulmonary arterial pressure, kwaye ekugqibeleni, ukungaphumeleli kwe-ventricular kunye nokufa kwangaphambi kwexesha.Iimpawu zakwangoko ze-PAH ziquka ukuphelelwa ngumphefumlo ngokuthe ngcembe, ukudinwa, ukubetha kwentliziyo, ukudumba, nokuquleka.